Accomplished Scientist to Lead BASi Global Research and Development
News May 18, 2011
BASi (Bioanalytical Systems Inc.), a leader in contract drug discovery and development services and research instrumentation, has hired Michael Zhou, Ph.D. as its new Senior Director of Research and Development.
Zhou joins BASi after working as the Director of Bioanalytical Chemistry/DMPK at Synta Pharmaceuticals Corporation in Lexington, Mass.
Zhou is a highly regarded expert on analytical/bioanalytical operations and regulatory compliance, including Good Laboratory Practice (GLP), cGMP, GCP regulations and ICH, GCLP, BMV guidelines.
He has given numerous presentations and workshops on these topics at conferences around the world. He has authored more than 50 research articles.
Zhou will guide the method development program and will be BASi's lead for the discovery bioanalytical support group.
"Michael's experience will consolidate our already strong reputation for developing the more challenging bioanalytical methods. In his R&D role, Michael will evaluate and implement new cost effective approaches to our bioanalytical process that will accelerate our growth and profitability," said President and Chief Executive Officer Anthony S. Chilton, Ph.D.
"We will increase our international exposure as Michael represents us in industry conferences, meetings and workshops."
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019